Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1264-1267

  Bradney, Alice P ^a,b   Scheer, Susan ^a,b   Crawford, John M ^a,b   Buchbinder, Susan P ^a,b   Montefiori, David C ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS ISOLATION; VIRUS LOAD; VIRUS NEUTRALIZATION;

HIV ANTIBODIES; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; NEUTRALIZATION TESTS; VIRAL LOAD;

EID: 0033046857     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314711     Document Type: Article

References (15)

1. 1. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
2. 2. Montefiori DC, Pantaleo G, Fink LM, et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term non-progressors. J Infect Dis 1996;173:60-7.
3. 3. Pilgrim AK, Pantaleo G, Cohen OJ, et al. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and longterm nonprogressive infection. J Infect Dis 1997;176:924-32.
4. 4. Zhang YJ, Fracasso C, Fiore JR, et al. Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HTV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. J Infect Dis 1997;176:1180-7.
5. + T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 1998;12:1591-600.
6. 6. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with longterm nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
7. 7. Harrer T, Harrer E, Kalams SA, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type 1 infection. AIDS Res Hum Retroviruses 1996;12: 585-92.
8. 8. Schwartz D, Sharma U, Busch M, et al. Absence of recoverable infectious virus and unique immune response in an asymptomatic HIV long-term survivor. AIDS Res Hum Retroviruses 1994;10:1703-11.
9. 9. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
10. 10. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
11. 11. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
12. 12. Fenyö EM, Albert J, McKeating J. The role of the humoral immune response in HIV infection. AIDS 1996; 10(suppl A):S97-106.
13. 13. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 1994;68:6672-83.
14. 14. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Longterm HIV-1 infection without immunological progression. AIDS 1994;8: 1123-8.
15. 15. Pellegrin I, Legrand E, Neau D, et al. Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:438-47.